Differently from what observed in patients with both bone and cardiovascular disease, the frequency of total (BD:.007% [IQR:.005–.019]; DN.005% [IQR:.003–.015], p = .34 Figure 2A), and CD161-expressing iNKT cells (BD: 62.3% [IQR: 50.7–90.7]; DN 56.3% [IQR 37.4–76.1]; p = .25; Fig. 2B) were comparable in the two groups. Here, KLRB1 is linked to Behcet disease.